SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System

DEVICE2 trials

Sponsors

SetPoint Medical Corporation

Conditions

Rheumatoid Arthritis

Unknown Phase

Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

CompletedNCT03437473

SetPoint Medical CorporationRheumatoid Arthritis

Start: 2018-03-06End: 2018-12-10Updated: 2018-12-27

Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

Active, not recruitingNCT04862117

SetPoint Medical CorporationRheumatoid Arthritis

Start: 2018-07-28End: 2026-12-08Updated: 2026-08-27

Related Papers

Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study.

2020-07-2880 citations